Evaluating the gene-expression profiles of hela cancer cells treated with activated and nonactivated poly(amidoamine) dendrimers, and their dna complexes

Molecular Pharmaceutics

Volumn 7, Issue 3, 2010, Pages 805-814

  Kuo, Jung Hua Steven ^a   Liou, Meng Jie ^a   Chiu, Hsueh Chen ^a  

^a CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

Activation; Human cervical cancer HeLa cells; Microarrays; Nonviral vectors; Poly(amidoamine) (PAMAM) dendrimers

Indexed keywords

DENDRIMER; METAL ION; NUCLEIC ACID; PLASMID DNA; POLYAMIDOAMINE;

ARTICLE; CANCER CELL; CANCER GENE THERAPY; CHEMICAL STRUCTURE; ENZYME ACTIVITY; GENE; GENE ACTIVATION; GENE CONTROL; GENE DELIVERY SYSTEM; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; UNINDEXED SEQUENCE; UTERINE CERVIX CANCER;

ARNTL TRANSCRIPTION FACTORS; AUTOANTIGENS; CARRIER PROTEINS; CELL SURVIVAL; DENDRIMERS; DNA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC VECTORS; HELA CELLS; HUMANS; MI-2 NUCLEOSOME REMODELING AND DEACETYLASE COMPLEX; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYAMINES; RECEPTORS, PURINERGIC P2;

EID: 77953245036     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp900303s     Document Type: Article

References (25)

1. Seow, Y.; Wood, M. J. Biological gene delivery vehicles: beyond viral vectors Mol. Ther. 2009, 17, 767-777
2. Kawakami, S.; Higuchi, Y.; Hashida, M. Nonviral approaches for targeted delivery of plasmid DNA and oligonucleotide J. Pharm. Sci. 2008, 97, 726-745
3. Gao, X.; Kim, K. S.; Liu, D. Nonviral gene delivery: what we know and what is next AAPS J. 2007, 9, E92-104
4. Louise, C. Nonviral vectors Methods Mol. Biol. 2006, 333, 201-226
5. Duf-s, C.; Uchegbu, I. F.; Schätzlein, A. G. Dendrimers in gene delivery Adv. Drug Delivery Rev. 2005, 57, 2177-2202
6. Dennig, J.; Duncan, E. Gene transfer into eukaryotic cells using activated polyamidoamine dendrimers J. Biotechnol. 2002, 90, 339-347
7. Tang, M. X.; Redemann, C. T.; Szoka, F. C. In vitro gene delivery by degraded polyamidoamine dendrimers Bioconjugate Chem. 1996, 7, 703-714
8. Navarro, G.; de ILarduya, C. T. Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo Nanomedicine 2009, 5, 287-297
9. Duf-s, C.; Keith, W. N; Bilsland, A.; Proutski, I.; Uchegbu, I. F.; Schätzlein, A. G. Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors Cancer Res. 2005, 65, 8079-8084
10. Chisholm, E. J.; Vassaux, G.; Martin-Duque, P.; Chevre, R.; Lambert, O.; Pitard, B.; Merron, A.; Weeks, M.; Burnet, J.; Peerlinck, I.; Dai, M. S.; Alusi, G.; Mather, S. J.; Bolton, K.; Uchegbu, I. F.; Schatzlein, A. G.; Baril, P. Cancer-specific transgene expression mediated by systemic injection of nanoparticles Cancer Res. 2009, 69, 2655-2662
11. Omidi, Y.; Hollins, A. J.; Drayton, R. M.; Akhtar, S. Polypropylenimine dendrimer-induced gene expression changes: the effect of complexation with DNA, dendrimer generation and cell type J. Drug Targeting 2005, 13, 431-443
12. Hollins, A. J.; Omidi, Y.; Benter, I. F.; Akhtar, S. Toxicogenomics of drug delivery systems: Exploiting delivery system-induced changes in target gene expression to enhance siRNA activity J. Drug Targeting 2007, 15, 83-88
13. Gras, R.; Almonacid, L.; Ortega, P.; Serramia, M. J.; Gomez, R.; de la Mata, F. J.; Lopez-Fernandez, L. A.; Munoz-Fernandez, M. A. Changes in gene expression pattern of human primary macrophages induced by carbosilane dendrimer 2G-NN16 Pharm. Res. 2009, 26, 577-586
14. Kuo, J. H.; Lin, Y. L. Remnant cationic dendrimers block RNA migration in electrophoresis after monophasic lysis J. Biotechnol. 2007, 129, 383-390
15. Akhtor, S. Beyond delivery Gene Ther. 2006, 13, 739-740
16. Trappe, R.; Ahmed, M.; Glaser, B.; Vogel, C.; Tascou, S.; Burfeind, P.; Engela, W. Identification and characterization of a novel murine multigene family containing a PHD-finger-like motif Biochem. Biophys. Res. Commun. 2002, 293, 816-826
17. Yeh, C. T.; Lu, S. C.; Tseng, I. C.; Lai, H. Y.; Tsao, M. L.; Huang, S. F.; Liaw, Y. F. Antisense overexpression of BMAL2 enhances cell proliferation Oncogene 2003, 22, 5306-5314
18. Osman, A. M.; van Kol, S.; Peijnenburg, A.; Blokland, M.; Pennings, J. L.; Kleinjans, J. C.; van Loveren, H. Proteomic analysis of mouse thymoma EL4 cells treated with bis(tri-n-butyltin)oxide (TBTO) J. Immunotoxicol. 2009, 6, 174-183
19. Srinivasan, R.; Mager, G. M.; Ward, R. M.; Mayer, J.; Svaren, J. NAB2 represses transcription by interacting with the CHD4 subunit of the nucleosome remodeling and deacetylase (NuRD) complex J. Biol. Chem. 2006, 281, 15129-15137
20. Ralevic, V.; Burnstock, G. Receptors for purines and pyrimidines Pharmacol. Rev. 1998, 50, 413-492
21. Khakh, B. S.; North, R. A. P2X receptors as cell-surface ATP sensors in health and disease Nature 2006, 442, 527-532
22. Nakanishi, H.; Mazda, O.; Satoh, E.; Asada, H.; Morioka, H.; Kishida, T. Nonviral genetic transfer of Fas ligand induced significant growth suppression and apoptotic tumor cell death in prostate can in vivo Gene Ther. 2003, 10, 434-442
23. Vincent, L.; Varet, J.; Pille, J. Y.; Bompais, H.; Opolon, P.; Makshimenko, A. Efficacy of dendrimer-mediated Angiostatin and TMP-2 gene delivery on inhibition of tumor growth and angiogenesis: In vitro and in vivo studies Int. J. Cancer 2003, 105, 419-429
24. Douglas, K. L. Toward development of artificial viruses for gene therapy: A comparative evaluation of viral and non-viral transfection Biotechnol. Prog. 2008, 24, 871-883
25. Bielinska, U.; Kukowska-Latallo, F.; Baker, J. R. The interaction of plasmid DNA with polyamidoamine dendrimers: mechanism of complex formation and analysis of alterations induced in nuclease sensitivity and transcriptional activity of the complexed DNA Biochim. Biophys. Acta 1997, 1353, 180-190